2 studies found for:    23281974 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Early Treatment With Sofosbuvir (SOF) and Ledipasvir (LDV) to Prevent HCV Recurrence After Liver Transplantation (OLT)
Condition: Hepatitis C Viral Infection
Intervention: Drug: Sofosbuvir (SOF) and Ledipasvir (LDV)
2 Completed
Has Results
Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3
Condition: Chronic Hepatitis C Infection
Interventions: Drug: SOF;   Drug: RBV;   Drug: PEG;   Drug: LDV;   Drug: GS-9669;   Drug: LDV/SOF

Indicates status has not been verified in more than two years